Advanced search
Publication Cover
International Journal of Neuroscience Volume 126, 2016 - Issue 11
Submit an article Journal homepage
357
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 – a retrospective case series

Mikkel Christian AlaninDepartment of Otolaryngology – Head and Neck Surgery and Audiology, Copenhagen University Hospital, Copenhagen, DenmarkCorrespondence[email protected]
,
Camilla KlausenDepartment of Radiology, Copenhagen University Hospital, Copenhagen, Denmark
,
Per Caye-ThomasenDepartment of Otolaryngology – Head and Neck Surgery and Audiology, Copenhagen University Hospital, Copenhagen, Denmark;Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
,
Carsten ThomsenDepartment of Radiology, Copenhagen University Hospital, Copenhagen, Denmark;Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
,
Kaare FugleholmDepartment of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark
,
Lars PoulsgaardDepartment of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark
,
Ulrik LassenDepartment of Oncology and Radiotherapy, Copenhagen University Hospital, Copenhagen, Denmark
,
Morten Mau-SorensenDepartment of Oncology and Radiotherapy, Copenhagen University Hospital, Copenhagen, Denmark
&
Kenneth Francis HoflandDepartment of Oncology and Radiotherapy, Copenhagen University Hospital, Copenhagen, Denmark
 show all
Pages 1002-1006 | Received 04 Jun 2015, Accepted 07 Sep 2015, Published online: 06 Oct 2015

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Xuexue Bai, Xiaomin Liu & Jun Wen. (2022) Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study. Neuropsychiatric Disease and Treatment 18, pages 1619-1627.
Read now
Alba Scerrati, Lorenzo Mongardi, Jacopo Visani, Giorgio Lofrese, Michele Alessandro Cavallo, Alba Fiorentino & Pasquale De Bonis. (2020) The controversial role of Bevacizumab in the treatment of patients with intracranial meningioma: a comprehensive literature review. Expert Review of Anticancer Therapy 20:3, pages 197-203.
Read now

Articles from other publishers (14)

Zheng Wang, Haining Chen, Qun Chen, Yucun Zhu, Min Li & Zhou Jia. (2023) ‘Sandwich treatment’ for posterior fossa brain metastases with volume larger than 4cm3: a multicentric retrospective study. Clinical & Experimental Metastasis.
Crossref
Prabhumallikarjun Patil, Bojana Borislavova Pencheva, Vinayak Mahesh Patil & Jason Fangusaro. (2022) Nervous system (NS) Tumors in Cancer Predisposition Syndromes. Neurotherapeutics 19:6, pages 1752-1771.
Crossref
Xuexue Bai & Meng Zhou. (2022) The benefit of bevacizumab therapy in patients with refractory vasogenic edema caused by brain metastasis from lung and colon cancers. Frontiers in Oncology 12.
Crossref
Lauren D. Sanchez, Ashley Bui & Laura J. Klesse. (2021) Targeted Therapies for the Neurofibromatoses. Cancers 13:23, pages 6032.
Crossref
Thomas Graillon, Loic Ferrer, Jason Siffre, Marc Sanson, Matthieu Peyre, Hadrien Peyrière, Grégory Mougel, Didier Autran, Emeline Tabouret, Dominique Figarella-Branger, Anne Barlier, Michel Kalamarides, Henry Dufour, Thierry Colin & Olivier Chinot. (2021) Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM study. Neuro-Oncology 23:7, pages 1139-1147.
Crossref
E. S. Makashova, S. V. Zolotova, V. V. Kostyuchenko, M. V. Galkin, M. A. Ginzberg, G. V. Danilov, N. A. Antipina, N. A. Konovalov & A. V. Golanov. (2021) Neurofibromatosis 2: new perspectives in treatment (case report). Russian journal of neurosurgery 23:1, pages 109-118.
Crossref
Rupesh Kotecha, Raees Tonse, Haley Appel, Yazmin Odia, Ritesh R. Kotecha, Guilherme Rabinowits & Minesh P. Mehta. (2021) Regression of Intracranial Meningiomas Following Treatment with Cabozantinib. Current Oncology 28:2, pages 1537-1543.
Crossref
Roy E StrowdIIIIII. (2020) Available Therapies for Patients with Neurofibromatosis-Related Nervous System Tumors. Current Treatment Options in Oncology 21:10.
Crossref
Maya Hrachova, Emely Nhi T. Nguyen, Beverly D. Fu, Manisha J. Dandekar, Xiao-Tang Kong, Gilbert Cadena, Frank P. K. Hsu, John Billimek, Thomas H. Taylor & Daniela A. Bota. (2020) A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas. Frontiers in Neurology 11.
Crossref
Andrew Look & Russell R. Lonser. 2020. Meningiomas, Part I. Meningiomas, Part I 121 129 .
Faliang Gao, Min Li, Zheng Wang, Lingfei Shi, Lin Lou & Jia Zhou. (2019) Efficacy and Safety of Gamma Knife Radiosurgery for Meningiomas in Patients with Neurofibromatosis Type 2: A Long-Term Follow-Up Single-Center Study. World Neurosurgery 125, pages e929-e936.
Crossref
Thien Nguyen, Lawrance K. Chung, John P. Sheppard, Nikhilesh S. Bhatt, Cheng Hao Jacky Chen, Carlito Lagman, Tania Kaprealian, Percy Lee, Phioanh L. Nghiemphu & Isaac Yang. (2017) Surgery versus stereotactic radiosurgery for the treatment of multiple meningiomas in neurofibromatosis type 2: illustrative case and systematic review. Neurosurgical Review 42:1, pages 85-96.
Crossref
Saksham Gupta, Wenya Linda Bi & Ian F. Dunn. (2018) Medical management of meningioma in the era of precision medicine. Neurosurgical Focus 44:4, pages E3.
Crossref
Katrina A. Morris, John F. Golding, Claire Blesing, D. Gareth Evans, Rosalie E. Ferner, Karen Foweraker, Dorothy Halliday, Raj Jena, Catherine McBain, Martin G. McCabe, Angela Swampillai, Nicola Warner, Shaun Wilson, Allyson Parry & Shazia K. Afridi. (2016) Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort. Journal of Neuro-Oncology 131:1, pages 117-124.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.